Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease
Authors
Keywords
-
Journal
PHARMACOLOGICAL RESEARCH
Volume 185, Issue -, Pages 106507
Publisher
Elsevier BV
Online
2022-10-15
DOI
10.1016/j.phrs.2022.106507
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heat Shock Protein 60 Restricts Release of Mitochondrial dsRNA to Suppress Hepatic Inflammation and Ameliorate Non-Alcoholic Fatty Liver Disease in Mice
- (2022) Ying-Hsien Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Supplementation with cyanidin and delphinidin mitigates high fat diet-induced endotoxemia and associated liver inflammation in mice
- (2022) Eleonora Cremonini et al. Food & Function
- Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease among 73,566 Individuals in Beijing, China
- (2022) Qianli Yuan et al. International Journal of Environmental Research and Public Health
- Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway
- (2022) Bin Jiang et al. Molecular Metabolism
- Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis
- (2022) Tadashi Namisaki et al. Indian Journal of Gastroenterology
- Corydalis saxicola Bunting Total Alkaloids ameliorate diet-induced non-alcoholic steatohepatitis by regulating hepatic PI3K/Akt and TLR4/NF-κB pathways in mice
- (2022) Jiejie Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- Obeticholic acid orchestrates the crosstalk between ileal autophagy and tight junctions in non-alcoholic steatohepatitis: Role of TLR4/TGF-β1 axis
- (2022) Rasha A. Tawfiq et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Marine Chitooligosaccharide Alters Intestinal Flora Structure and Regulates Hepatic Inflammatory Response to Influence Nonalcoholic Fatty Liver Disease
- (2022) Jiayao Feng et al. Marine Drugs
- Gynostemma pentaphyllum polysaccharides ameliorate non-alcoholic steatohepatitis in mice associated with gut microbiota and the TLR2/NLRP3 pathway
- (2022) Si-Ran Yue et al. Frontiers in Endocrinology
- Role of Toll‐like receptors in the pathogenesis of COVID‐19
- (2021) Shaghayegh Khanmohammadi et al. JOURNAL OF MEDICAL VIROLOGY
- Astragaloside IV Improves High-Fat Diet–Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling Pathway
- (2021) Ying-Li Liu et al. Frontiers in Pharmacology
- Toll‐like receptor 5 and 8 in hepatocellular carcinoma
- (2021) Valtteri Kairaluoma et al. APMIS
- Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASH
- (2021) Katharina Luise Hupa-Breier et al. Biomedicines
- SAA1/TLR2 axis directs chemotactic migration of hepatic stellate cells responding to injury
- (2021) Anteneh Getachew et al. iScience
- Hepatic Macrophages Express Melanoma Differentiation-Associated Gene 5 in Nonalcoholic Steatohepatitis
- (2021) Shogo Kawaguchi et al. INFLAMMATION
- Toll-like receptor 3 ablation prevented high-fat diet-induced obesity and metabolic disorder
- (2021) Guoqing Zhang et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4
- (2021) Khaoula Errafii et al. Journal of Translational Medicine
- Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses
- (2021) Yujuan Chen et al. Journal of Zhejiang University-SCIENCE B
- A genetic variant in toll‐like receptor 5 is linked to chemokine levels and hepatocellular carcinoma in steatohepatitis
- (2021) Hans Dieter Nischalke et al. LIVER INTERNATIONAL
- Attenuating Effects of Dieckol on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Decreasing the NLRP3 Inflammasome and Pyroptosis
- (2021) Seyeon Oh et al. Marine Drugs
- Taurine ameliorates thioacetamide induced liver fibrosis in rats via modulation of toll like receptor 4/nuclear factor kappa B signaling pathway
- (2021) Nancy S. Younis et al. Scientific Reports
- Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
- (2021) Anja Baumann et al. Scientific Reports
- Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease
- (2021) Mao-xing Pan et al. Journal of Integrative Medicine-JIM
- LncRNA TLR8-AS1 suppresses miR-34a maturation in hepatocellular carcinoma to suppress cell proliferation and migration
- (2021) Xin Shi et al. MAMMALIAN GENOME
- Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota
- (2021) Karolina Drożdż et al. Nutrients
- The Effects of Pathogen-Associated Molecular Patterns on Peripheral Blood Monocytes in Patients with Non-alcoholic Fatty Liver Disease
- (2021) Qian Li et al. Journal of Clinical and Experimental Hepatology
- Toll-Like Receptor 5 Signaling Ameliorates Liver Fibrosis by Inducing Interferon β–Modulated IL-1 Receptor Antagonist in Mice
- (2020) Zixiong Zhou et al. AMERICAN JOURNAL OF PATHOLOGY
- Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice
- (2020) Jin Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Regulation of lipid‐induced macrophage polarization through modulating PPAR‐γ activity affects hepatic lipid metabolism via TLR4/NF‐κB signaling pathway
- (2020) Hui‐Min Wu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Direct inhibition of TLR4/MyD88 pathway by geniposide suppresses HIF1α‐independent VEGF expression and hepatocellular carcinoma angiogenesis
- (2020) Cheng Zhang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mitochondrial DNA from hepatocytes induces upregulation of interleukin-33 expression of macrophages in nonalcoholic steatohepatitis
- (2020) Yinjie Gao et al. DIGESTIVE AND LIVER DISEASE
- TLR3 promotes hepatocyte proliferation after partial hepatectomy by stimulating uPA expression and the release of tissue‐bound HGF
- (2020) Christian Stöß et al. FASEB JOURNAL
- Exenatide ameliorates experimental non-alcoholic fatty liver in rats via suppression of toll-like receptor 4/NFκB signaling: Comparison to metformin
- (2020) Zeinab A. Saad et al. LIFE SCIENCES
- Inulin Exerts Beneficial Effects on Non-Alcoholic Fatty Liver Disease via Modulating gut Microbiome and Suppressing the Lipopolysaccharide-Toll-Like Receptor 4-Mψ-Nuclear Factor-κB-Nod-Like Receptor Protein 3 Pathway via gut-Liver Axis in Mice
- (2020) Ting Bao et al. Frontiers in Pharmacology
- Small Bowel Resection Increases Paracellular Gut Barrier Permeability via Alterations of Tight Junction Complexes Mediated by Intestinal TLR4
- (2020) Cathleen M. Courtney et al. JOURNAL OF SURGICAL RESEARCH
- Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis
- (2019) Noha F. Hassan et al. INFLAMMATION
- Dieckol or phlorofucofuroeckol extracted from Ecklonia cava suppresses lipopolysaccharide-mediated human breast cancer cell migration and invasion
- (2019) Young-Ju Lee et al. JOURNAL OF APPLIED PHYCOLOGY
- Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4/NF-κB signaling pathway in mice
- (2019) Beibei Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Increased liver localization of lipopolysaccharides in human and experimental non‐alcoholic fatty liver disease
- (2019) Guido Carpino et al. HEPATOLOGY
- Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease
- (2018) J.T. Qiao et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Toll-Like Receptor-7 Signaling Promotes Nonalcoholic Steatohepatitis by Inhibiting Regulatory T Cells in Mice
- (2018) Yoon Seok Roh et al. AMERICAN JOURNAL OF PATHOLOGY
- Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation
- (2017) David Porras et al. FREE RADICAL BIOLOGY AND MEDICINE
- Transmembrane BAX Inhibitor motif-containing 1, a novel anti-inflammatory approach for nonalcoholic steatohepatitis treatment
- (2017) Alexander Wree et al. HEPATOLOGY
- Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth through HMGB1 and TLR9 interaction
- (2017) Samer Tohme et al. HEPATOLOGY
- Toll-like receptor 4 is critical for the development of resection-associated hepatic steatosis
- (2017) Lauren K. Barron et al. JOURNAL OF PEDIATRIC SURGERY
- Toll like receptor 4 and hepatocellular carcinoma; A systematic review
- (2017) Zahra Sepehri et al. LIFE SCIENCES
- Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4
- (2017) Guang-Nian Zhao et al. NATURE MEDICINE
- Inhibition of MAPK and NF-κB signaling pathways alleviate carbon tetrachloride (CCl4)-induced liver fibrosis in Toll-like receptor 5 (TLR5) deficiency mice
- (2016) Ming Shu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models
- (2016) Mitsuaki Ishioka et al. DIGESTIVE DISEASES AND SCIENCES
- Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by γδ T cells in liver fibrosis
- (2016) Wonhyo Seo et al. HEPATOLOGY
- Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9
- (2016) Irma Garcia-Martinez et al. JOURNAL OF CLINICAL INVESTIGATION
- TLR4-dependent signaling pathway modulation: A novel mechanism by which pioglitazone protects against nutritional fibrotic steatohepatitis in mice
- (2016) JINGHUA DU et al. Molecular Medicine Reports
- TLR7 agonist induced repression of hepatocellular carcinoma via the TLR7-IKK-NF-κB-IL6 signaling pathway
- (2016) XINGBIN REN et al. Oncology Letters
- Lipid rafts promote liver cancer cell proliferation and migration by up-regulation of TLR7 expression
- (2016) Yuan Liu et al. Oncotarget
- Toll-like receptor 7 affects the pathogenesis of non-alcoholic fatty liver disease
- (2016) Sokho Kim et al. Scientific Reports
- Isolated exopolysaccharides from Lactobacillus rhamnosus GG alleviated adipogenesis mediated by TLR2 in mice
- (2016) Zhen Zhang et al. Scientific Reports
- TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis
- (2015) Ming-Ming Yuan et al. BMC CANCER
- TLR2 Limits Development of Hepatocellular Carcinoma by Reducing IL18-Mediated Immunosuppression
- (2015) S. Li et al. CANCER RESEARCH
- Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling
- (2015) Robert Caesar et al. Cell Metabolism
- Role of serum toll-like receptors 2 and 4 in non-alcoholic steatohepatitis and liver fibrosis
- (2015) Mustafa Cengiz et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Berberine Prevents Intestinal Mucosal Barrier Damage During Early Phase of Sepsis in Rat through the Toll-Like Receptors Signaling Pathway
- (2015) Guo-xun Li et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression
- (2015) Victor Ho et al. Oncotarget
- TLR4 signaling promotes a COX-2/PGE2/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells
- (2015) Ang Lin et al. OncoImmunology
- Toll like receptor 2 knock-out attenuates carbon tetrachloride (CCl4)-induced liver fibrosis by downregulating MAPK and NF-κB signaling pathways
- (2014) Lingling Ji et al. FEBS LETTERS
- Intestinal Epithelial Cell Toll-like Receptor 5 Regulates the Intestinal Microbiota to Prevent Low-Grade Inflammation and Metabolic Syndrome in Mice
- (2014) Benoit Chassaing et al. GASTROENTEROLOGY
- Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma
- (2014) Fatma E. Mohamed et al. LIVER INTERNATIONAL
- Recognition of LPS by TLR4: Potential for Anti-Inflammatory Therapies
- (2014) Reindert Nijland et al. Marine Drugs
- Suppression of toll-like receptor 2 expression inhibits the bioactivity of human hepatocellular carcinoma
- (2014) Wenna Shi et al. TUMOR BIOLOGY
- Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease
- (2014) Kouichi Miura WORLD JOURNAL OF GASTROENTEROLOGY
- Regulation of Intestinal Immune Responses through TLR Activation: Implications for Pro- and Prebiotics
- (2014) Sander de Kivit et al. Frontiers in Immunology
- Betaine Protects Against High-Fat-Diet-Induced Liver Injury by Inhibition of High-Mobility Group Box 1 and Toll-Like Receptor 4 Expression in Rats
- (2013) Wei Zhang et al. DIGESTIVE DISEASES AND SCIENCES
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis
- (2013) Yoon Seok Roh et al. HEPATOLOGY
- Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis
- (2013) Noemí Eiró et al. HEPATOLOGY RESEARCH
- Hepatic stellate cells in liver development, regeneration, and cancer
- (2013) Chunyue Yin et al. JOURNAL OF CLINICAL INVESTIGATION
- Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis
- (2013) Yusaku Shirai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease
- (2013) Giridhar Kanuri et al. LIVER INTERNATIONAL
- Antioxidant N-Acetylcysteine Attenuates Hepatocarcinogenesis by Inhibiting ROS/ER Stress in TLR2 Deficient Mouse
- (2013) Heng Lin et al. PLoS One
- Natural Killer Cell-Dependent Anti-Fibrotic Pathway in Liver Injury via Toll-Like Receptor-9
- (2013) Lina Abu-Tair et al. PLoS One
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- Protective effects of curcumin against hepatic fibrosis induced by carbon tetrachloride: Modulation of high-mobility group box 1, Toll-like receptor 4 and 2 expression
- (2012) Chuan-tao Tu et al. FOOD AND CHEMICAL TOXICOLOGY
- Toll-Like Receptor 2–Mediated Intestinal Injury and Enteric Tumor Necrosis Factor Receptor I Contribute to Liver Fibrosis in Mice
- (2012) Phillipp Hartmann et al. GASTROENTEROLOGY
- Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice
- (2012) Kouichi Miura et al. HEPATOLOGY
- Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice
- (2012) Heng Lin et al. HEPATOLOGY
- Loss of toll-like receptor 3 function improves glucose tolerance and reduces liver steatosis in obese mice
- (2012) Linda H. Wu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway
- (2012) Haitao Shi et al. TOXICOLOGY
- Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice
- (2011) Timea Csak et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Toll-like receptors 1–9 are elevated in livers with fructose-induced hepatic steatosis
- (2011) Sabine Wagnerberger et al. BRITISH JOURNAL OF NUTRITION
- Combination of Poly I:C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells
- (2011) Peng Shen et al. CELL BIOLOGY INTERNATIONAL
- Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis
- (2011) Ekihiro Seki et al. HEPATOLOGY RESEARCH
- Toll-like receptors in acute liver injury and regeneration
- (2011) Yongyan Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH
- (2011) Erwin Gäbele et al. JOURNAL OF HEPATOLOGY
- Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
- (2010) Chantal A Rivera et al. BMC GASTROENTEROLOGY
- Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
- (2010) Kouichi Miura et al. GASTROENTEROLOGY
- Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver
- (2010) Kumaravelu Jagavelu et al. HEPATOLOGY
- Flagellin delays spontaneous human neutrophil apoptosis
- (2010) Gabriela V Salamone et al. LABORATORY INVESTIGATION
- Toll-Like Receptor Signaling and Liver Fibrosis
- (2010) Tomonori Aoyama et al. Gastroenterology Research and Practice
- Hematopoietic Cell-Specific Deletion of Toll-like Receptor 4 Ameliorates Hepatic and Adipose Tissue Insulin Resistance in High-Fat-Fed Mice
- (2009) Maziyar Saberi et al. Cell Metabolism
- Pioglitazone Inhibits Toll-Like Receptor Expression and Activity in Human Monocytes and db/db Mice
- (2009) Mohan R. Dasu et al. ENDOCRINOLOGY
- High-Fat Diet Determines the Composition of the Murine Gut Microbiome Independently of Obesity
- (2009) Marie A. Hildebrandt et al. GASTROENTEROLOGY
- Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice
- (2009) Astrid Spruss et al. HEPATOLOGY
- Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific
- (2009) Jun Wu et al. IMMUNOLOGY
- Role of TLR9 in hepatic stellate cells and experimental liver fibrosis
- (2008) Erwin Gäbele et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Toll‐like receptors and adaptor molecules in liver disease: Update
- (2008) Ekihiro Seki et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search